| Product Code: ETC7656450 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Motor Neurone Disease (MND) Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Motor Neurone Disease (MND) Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Motor Neurone Disease (MND) Market - Industry Life Cycle |
3.4 Israel Motor Neurone Disease (MND) Market - Porter's Five Forces |
3.5 Israel Motor Neurone Disease (MND) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Motor Neurone Disease (MND) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Israel Motor Neurone Disease (MND) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Israel Motor Neurone Disease (MND) Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Israel Motor Neurone Disease (MND) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Israel Motor Neurone Disease (MND) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of motor neurone disease (MND) in Israel |
4.2.2 Technological advancements in the healthcare sector leading to improved treatment options |
4.2.3 Rising healthcare expenditure and government initiatives to improve neurological care |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatments and therapies for MND |
4.3.2 High cost associated with the management and treatment of MND in Israel |
4.3.3 Lack of specialized healthcare professionals and facilities for MND patients |
5 Israel Motor Neurone Disease (MND) Market Trends |
6 Israel Motor Neurone Disease (MND) Market, By Types |
6.1 Israel Motor Neurone Disease (MND) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Amyotrophic lateral sclerosis (ALS), 2021- 2031F |
6.1.4 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive bulbar palsy (PBP), 2021- 2031F |
6.1.5 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive muscular atrophy (PMA), 2021- 2031F |
6.1.6 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Primary lateral sclerosis (PLS), 2021- 2031F |
6.2 Israel Motor Neurone Disease (MND) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Physiotherapy, 2021- 2031F |
6.2.4 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.2.5 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Motor Neurone Disease (MND) Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Blood test, 2021- 2031F |
6.3.3 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Electromyography (EMG), 2021- 2031F |
6.3.4 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By MRI Scan, 2021- 2031F |
6.3.5 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Transcranial magnetic stimulation (TMS), 2021- 2031F |
6.3.6 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Motor Neurone Disease (MND) Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Motor Neurone Disease (MND) Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Israel Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Motor Neurone Disease (MND) Market Import-Export Trade Statistics |
7.1 Israel Motor Neurone Disease (MND) Market Export to Major Countries |
7.2 Israel Motor Neurone Disease (MND) Market Imports from Major Countries |
8 Israel Motor Neurone Disease (MND) Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for MND patients |
8.2 Number of clinical trials and research studies focused on MND in Israel |
8.3 Patient satisfaction and quality of life improvements post-treatment |
8.4 Adoption rate of innovative technologies and therapies for MND management |
9 Israel Motor Neurone Disease (MND) Market - Opportunity Assessment |
9.1 Israel Motor Neurone Disease (MND) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Motor Neurone Disease (MND) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Israel Motor Neurone Disease (MND) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Israel Motor Neurone Disease (MND) Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Israel Motor Neurone Disease (MND) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Israel Motor Neurone Disease (MND) Market - Competitive Landscape |
10.1 Israel Motor Neurone Disease (MND) Market Revenue Share, By Companies, 2024 |
10.2 Israel Motor Neurone Disease (MND) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here